A detailed history of Hussman Strategic Advisors, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 42,000 shares of COLL stock, worth $1.24 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
42,000
Holding current value
$1.24 Million
% of portfolio
0.42%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$31.4 - $39.07 $1.32 Million - $1.64 Million
42,000 New
42,000 $1.62 Million
Q4 2020

Feb 01, 2021

SELL
$17.83 - $22.29 $1.82 Million - $2.27 Million
-102,000 Closed
0 $0
Q3 2020

Nov 02, 2020

BUY
$15.78 - $20.82 $1.61 Million - $2.12 Million
102,000 New
102,000 $2.12 Million

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.01B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Hussman Strategic Advisors, Inc. Portfolio

Follow Hussman Strategic Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.